BRIEF published on 10/13/2026 at 10:05, 1 month 7 days ago PL BioScience présente PL Synergy pour une recherche améliorée sur les CSM PL BioScience Synergie PL Recherche MSC Extension Sans Xéno Kit De Culture Cellulaire
BRIEF published on 10/13/2026 at 10:05, 1 month 7 days ago PL BioScience Introduces PL Synergy for Enhanced MSC Research PL BioScience PL Synergy MSC Research Xeno-free Expansion Cell Culture Kit
PRESS RELEASE published on 10/13/2026 at 10:00, 1 month 7 days ago PL BioScience Launches PL Synergy to Simplify and Standardize MSC Research PL BioScience launches PL Synergy, a two-component culture kit designed to simplify and standardize MSC research. The kit combines PL Base and PL Boost for streamlined xeno-free MSC expansion PL BioScience PL Synergy MSC Research Culture Kit Xeno-free
BRIEF published on 06/16/2026 at 10:05, 5 months 4 days ago PL BioScience accueille Maik W. Jornitz au sein de son conseil d'administration. Conseil D'administration Croissance Biopharmaceutique Lysat Plaquettaire Humain PL BioScience Maik W. Jornitz
BRIEF published on 06/16/2026 at 10:05, 5 months 4 days ago PL BioScience Welcomes Maik W. Jornitz to Board of Directors Board Of Directors Biopharmaceutical Growth Human Platelet Lysate PL BioScience Maik W. Jornitz
PRESS RELEASE published on 06/16/2026 at 10:00, 5 months 4 days ago PL BioScience Appoints Maik W. Jornitz to Board of Directors PL BioScience GmbH appoints Maik W. Jornitz to its board of directors, bringing four decades of biopharmaceutical experience to accelerate global growth Board Of Directors Biopharmaceutical Global Growth PL BioScience GmbH Maik W. Jornitz
BRIEF published on 02/20/2026 at 09:05, 9 months ago PL BioScience conclut un accord de distribution exclusif au Japon avec Summit Pharmaceuticals Accord De Distribution Marché Japonais PL BioScience Suppléments Pour Culture Cellulaire Summit Pharmaceuticals
BRIEF published on 02/20/2026 at 09:05, 9 months ago PL BioScience Secures Exclusive Japanese Distribution Deal with Summit Pharmaceuticals Distribution Agreement Japanese Market PL BioScience Cell Culture Supplements Summit Pharmaceuticals
PRESS RELEASE published on 02/20/2026 at 09:00, 9 months ago PL BioScience Signs Exclusive Japanese Distribution Agreement with Summit Pharmaceuticals International PL BioScience signs exclusive distribution agreement with Summit Pharmaceuticals International for cell culture supplements in Japan, marking their first partnership in the country Japanese Market Exclusive Agreement PL BioScience Cell Culture Supplements Summit Pharmaceuticals International
BRIEF published on 02/11/2026 at 10:05, 9 months 9 days ago PL BioScience Secures Certification from Japan's PMDA Regenerative Medicine Human Platelet Lysate PL BioScience PMDA Certification ELAREM™ Ultimate-FD PLUS
Published on 11/20/2026 at 15:00, 13 hours 35 minutes ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 13 hours 45 minutes ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 14 hours 35 minutes ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 15 hours 5 minutes ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 15 hours 5 minutes ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 4 hours 50 minutes ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 22:39, 5 hours 56 minutes ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 6 hours 59 minutes ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 7 hours 46 minutes ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 10 hours ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 10 hours ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 11 hours ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 11 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 1 day 9 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR